Genes that hold the clues to bladder cancer and its treatment
Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer - and it could open up the possibility of better-targeted treatment,...
NEWS INDEX
Cellular network identified that ‘short circuits’ the antitumor effect of immunotherapies
PHILADELPHIA -- (Nov. 13, 2017) -- Researchers from The Wistar Institute discovered a novel form of crosstalk among tumor cells and other cell types in...
Harder for T cells to fight cancer in absence of VEGF-A
Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment when they have access to...
Engineering non-immune cells to kill cancer cells
Credit: ETH Zurich T-cells are one of the immune system's major weapons. They detect the body's cells infected with a virus and trigger their ablation,...
‘Mini liver tumors’ created in a dish for the first time
Scientists have created mini biological models of human primary liver cancers, known as organoids, in the lab for the first time. In a paper published...
Ludwig scientists share findings at 2017 Society for Neuro-oncology Annual Meeting
NOVEMBER 13, 2017, NEW YORK - Ludwig Cancer Research has released the scope of its participation at this year's Annual Meeting and Education Day of...
ESMO Precision Medicine Glossary published today
LUGANO, Switzerland, 13 November, 2017 - ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication of the ESMO Precision Medicine...
PharmaMar presents positive results from a Phase II study of PM1183 in Ewing’s sarcoma
(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing´s sarcoma at the Connective Tissue Oncology Society´s (CTOS) International...
Epigenetic editing reveals surprising insights into early breast cancer development
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according...
Cancer immunotherapy uses melanin against melanoma
Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The...
Ludwig researchers uncover novel mechanism by which tumors evade cancer immunotherapies
NOVEMBER 10, 2017, New York -- A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel...
Patients with depression and advanced cancer survive longer with palliative care intervention
Credit: Figure by Anna T. Prescott. A new Dartmouth-led study finds that patients with depression and advanced cancer live longer when exposed to palliative care...
Uneven growth in US medical and health R&D investments across sectors
ARLINGTON, Va. -- Nov. 10, 2017 -- Total U.S. investment in medical and health R&D in the U.S. grew by 20.6% from 2013 to 2016...
Researchers exploit rhythm of DNA replication to kill cancer cells
New DNA is generated in human cells from tiny building blocks called nucleotides produced by an enzyme called RNR. Until now, we have not fully...
Bentham Science Publishers launches Oncology Collection
Bentham Science Publishers announces the launch of disease-based collections. The first of these collections is the Oncology article collection. This collection brings all of Bentham's...
